The Latest Cardiac and Vascular News
July 24, 2024 08:00 AM Eastern Daylight Time KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies, Inc., a privately held wearable medical device and digital healthcare company, today announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with its modern Wearable Cardioverter Defibrillator (WCD). […]
SEATTLE–(BUSINESS WIRE)–Kestra Medical Technologies is launching the ASSURE Clinician Experience (ACE), a program that lets electrophysiology and cardiology professionals wear and simulate use of the ASSURE® Wearable Cardioverter Defibrillator (WCD) system at The Heart Rhythm Society #HRX2023 global health and technology conference, September 21-23, 2023 in Seattle, WA. Clinicians that participate will be measured, fit, and trained in […]
ASSURE System Honored as One of the Year’s Best Designed Cardiovascular Devices KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies announced today that the company’s ASSURE® Wearable Cardioverter Defibrillator (WCD) system was recognized as one of the winners of the(MDEA), garnering honors in the Cardiovascular Devices category. The ASSURE® WCD system represents the next generation of monitoring and therapy to protect patients at […]
